S 2608
115th Congress
Senate
Health
Drug safety, medical device, and laboratory regulation
Drug trafficking and controlled substances
Health personnel
Prescription drugs
Reducing Opioid Risk Act
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 22, 2018
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Mar 22, 2018
Introduced in Senate
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Plain-English summary
Reducing Opioid Risk Act
This bill amends the Federal Food, Drug, and Cosmetic Act to expand the authority of the Food and Drug Administration to require a drug manufacturer to inform health care providers about state and federal regulations for controlled substances, including the partial fill option.
What's happening now
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Related & companion bills
1
Bill text
1 version
- Introduced in Senate Formatted Text PDF Formatted XML
Committees of jurisdiction
1
Cosponsors
1
Cite this page
U.S. Congress. (2026). S. 2608: Reducing Opioid Risk Act. 115th Congress. Open America. https://openamerica.io/bill/115-S-2608/
"S. 2608: Reducing Opioid Risk Act." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-S-2608/.
S. 2608, 115th Cong. (2026), https://openamerica.io/bill/115-S-2608/.
[S. 2608: Reducing Opioid Risk Act](https://openamerica.io/bill/115-S-2608/)